3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
56
Lung Neoplasms
27
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Neoplasms
5
Neoplasm Metastasis
4
Colorectal Neoplasms
4
Colonic Neoplasms
3
Advanced Solid Tumors
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Non-squamous Non-small Cell Lung Cancer
2
Mesothelioma
2
Meningeal Carcinomatosis
2
Melanoma
2
Lung Diseases
2
Esophageal Neoplasms
2
Carcinoma
2
Adenocarcinoma of Lung
2
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pathologic Processes
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Interventions
Radiosurgery
11
Temozolomide
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nivolumab
4
Mental Status and Dementia Tests
4
Receptors, Interleukin-8B
3
Memantine
3
Ipilimumab
3
trastuzumab deruxtecan
2
pembrolizumab
2
Surveys and Questionnaires
2
sotorasib
1
sapanisertib
1
sacituzumab govitecan
1
pertuzumab
1
patritumab deruxtecan
1
nabiximols
1
fluciclovine F-18
1
entrectinib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
brodalumab
1
auricularum
1
abemaciclib
1
Watchful Waiting
1
Vorinostat
1
Vitamin B 6
1
Valacyclovir
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Pemetrexed
×
30 days
×
Clear all
NCT05012254
2026-05-05
NIVIPI-Brain
Fundación GECP
Phase 2
Active not recruiting
71 enrolled